Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Phase III Study of ThermoDox in Combination with Radiofrequency Ablation vs Radiofrequency Ablation Alone in Non-Resectable Hepatocellular Carcinoma
KCT0000523Phase 3Terminated
- Sponsor
- Imunon, Inc.
- Start
- Aug 2008
- Modality
- DNA Intercalators/Alkylators → Nucleic Acid-Directed Small Molecules → Small Molecules, Classical Binding Small Molecules → Small Molecules, Covalent Small Molecules → Small Molecules
- Countries
- 1
01
Overview
A Phase 3 trial of doxorubicin in hepatocellular carcinoma (HCC), sponsored by Imunon, Inc.. Started Aug 2008; status: terminated.
02
Drugs
doxorubicin
03
Conditions
hepatocellular carcinoma (HCC)
Beyond the preview
Go deeper on KCT0000523.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on KCT0000523.